M9179
Meglumine
99.0-100.5% dry basis, meets USP testing specifications
別名:
N-メチル-D-グルカミン, 1-デオキシ-1-（メチルアミノ）-D-グルシトール, メグルミン
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
実験式（ヒル表記法）:
C7H17NO5
CAS番号:
分子量:
195.21
NACRES:
NA.21
UNSPSC Code:
12352104
PubChem Substance ID:
EC Number:
228-506-9
Beilstein/REAXYS Number:
385906
MDL number:
InChI key
MBBZMMPHUWSWHV-BDVNFPICSA-N
InChI
1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1
SMILES string
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
biological source
synthetic (organic)
agency
USP/NF, meets USP testing specifications
assay
99.0-100.5% dry basis
form
powder
autoignition temp.
~662 °F
color
off-white
mp
129-131.5 °C (lit.)
solubility
water: soluble
application(s)
pharmaceutical (small molecule)
storage temp.
room temp
Quality Level
類似した製品をお探しですか？ 訪問 製品比較ガイド
Application
- Pentavalent Antimony Associated with G-CSF in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) braziliensis: Investigates the use of meglumine in conjunction with G-CSF, showing potential for enhanced treatment outcomes (Suprien et al., 2024).
Other Notes
To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.
保管分類
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
M9179-VAR: + M9179-BULK: + M9179-100G: + M9179-1KG: + M9179-500G: + M9179-100MG:
jan
Philipp Kickingereder et al.
Neuro-oncology, 17(8), 1139-1147 (2015-03-11)
To analyze the relevance of dynamic susceptibility-weighted contrast-enhanced MRI (DSC-MRI) derived relative cerebral blood volume (rCBV) analysis for predicting response to bevacizumab (BEV) in patients with recurrent glioblastoma (rGB). A total of 127 patients diagnosed with rGB receiving either bevacizumab
Ntobeko A B Ntusi et al.
JACC. Cardiovascular imaging, 8(5), 526-536 (2015-04-22)
The goal of this study was to assess the diffuse myocardial fibrosis and edema in rheumatoid arthritis (RA) using multiparametric cardiac magnetic resonance (CMR) and the association of myocardial T1 and extracellular volume (ECV) with disease activity, duration, and cardiac
Alexander Radbruch et al.
Radiology, 275(3), 783-791 (2015-04-08)
To compare changes in signal intensity (SI) ratios of the dentate nucleus (DN) and the globus pallidus (GP) to those of other structures on unenhanced T1-weighted magnetic resonance (MR) images between linear and macrocyclic gadolinium-based contrast agents (GBCAs). The study
Andrea Barison et al.
Journal of cardiovascular medicine (Hagerstown, Md.), 16(10), 681-687 (2015-06-20)
In nonischaemic dilated cardiomyopathy (NICM), replacement myocardial fibrosis as detected by late gadolinium enhancement (LGE) at cardiovascular magnetic resonance (CMR) is associated with poor prognosis. We investigated the as-yet unexplored prognostic significance of interstitial fibrosis in NICM, using T1-mapping CMR.
Charlotte Manisty et al.
Radiology, 276(3), 732-740 (2015-04-30)
To investigate the pharmacology and potential clinical utility of splenic switch-off to identify understress in adenosine perfusion cardiac magnetic resonance (MR) imaging. Splenic switch-off was assessed in perfusion cardiac MR examinations from 100 patients (mean age, 62 years [age range
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）